Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Keros Therapeutics (KROS) Prepaid Assets: 2019-2024

Historic Prepaid Assets for Keros Therapeutics (KROS) over the last 6 years, with Dec 2024 value amounting to $26.2 million.

  • Keros Therapeutics' Prepaid Assets rose 6.53% to $22.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $22.3 million, marking a year-over-year increase of 6.53%. This contributed to the annual value of $26.2 million for FY2024, which is 63.84% up from last year.
  • According to the latest figures from FY2024, Keros Therapeutics' Prepaid Assets is $26.2 million, which was up 63.84% from $16.0 million recorded in FY2023.
  • Over the past 5 years, Keros Therapeutics' Prepaid Assets peaked at $26.2 million during FY2024, and registered a low of $1.9 million during FY2020.
  • Over the past 3 years, Keros Therapeutics' median Prepaid Assets value was $16.0 million (recorded in 2023), while the average stood at $16.3 million.
  • Data for Keros Therapeutics' Prepaid Assets shows a peak YoY skyrocketed of 385.56% (in 2020) over the last 5 years.
  • Yearly analysis of 5 years shows Keros Therapeutics' Prepaid Assets stood at $1.9 million in 2020, then surged by 83.68% to $3.4 million in 2021, then soared by 97.73% to $6.7 million in 2022, then soared by 138.18% to $16.0 million in 2023, then skyrocketed by 63.84% to $26.2 million in 2024.